Dow Jones Top Company Headlines at 7 PM ET: Chevron, Other U.S. Firms Near Deal to Invest Billions in Venezuelan Oil Fields | Gap ...

Chevron, Other U.S. Firms Near Deal to Invest Billions in Venezuelan Oil Fields

The U.S. oil major is close to an agreement to add two heavy-oil fields to its portfolio in Venezuela. Halliburton is also in talks.

----

Gap Is Back. Investors Are Starting to Believe.

The brand that set American style for much of the '90s and early 2000s has been undergoing a renaissance.

----

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

BioNTech says it's ending a Phase 2 trial for its investigational personalized mRNA cancer vaccine. It was being tested to treat colorectal cancer.

----

Google Tweaks Site Ranking Policy in Most of Europe to Avert Antitrust Fine

The company is changing how it enforces its site reputation policy within the European Economic Area, to appease regulators and avoid a potentially hefty fine.

----

Judge Rules Trump Administration's Blacklisting of Anthropic Was Unlawful

A judge said the labeling of Anthropic as a supply-chain risk constituted "unlawful retaliation" and violated the company's First Amendment rights.

----

BYD's Overseas Push Drives Quarterly Profit Growth

BYD's net profit rebounded despite slightly lower revenue in the second quarter, showing that the world's top electric-vehicle seller may have turned a corner with the help of its rapid expansion overseas.

----

PayPal Shares Dive Premarket on Report of Advent, Stripe Abandoning Takeover Plan

Shares in PayPal fell nearly 15% premarket to $52.47 a share.

----

Chinese Chip Maker CXMT Cashes In on AI-Fueled Memory Crunch

Blockbuster earnings from one of China's biggest memory chip-makers provides the latest evidence of how companies are cashing in on the global memory shortage.

----

Generali Mulling Monte dei Paschi's $10 Billion Takeover Bid for Banca Generali

The private bank's majority shareholder confirmed its willingness to evaluate the proposal, saying it envisioned new growth opportunities for both companies.

----

The L3Harris Shake-Up Is an Opportunity to Bet on Missile Rearmament

The defense contractor's shares have had a punishing year amid headlines that don't hurt its solid fundamentals.

----

Ulta Beauty Stock Falls After Upbeat Earnings

Ulta Beauty would like to put a couple of ugly quarters behind it.

----

Nvidia Insists It Can Keep Printing Money to Fund the AI Boom

The chip maker says its sales "flywheel" is more than robust enough to fund the financial support it gives frontier AI labs and data-center developers.

----

Affirm Stock Surged After Earnings. A Big Shopify Deal Is Adding Fuel.

Affirm posts better-than-expected revenue and gross merchandise volume in its fiscal fourth quarter.

----

U.S. Servicemember, KPMG Employee Are Targets of Prediction Markets Crackdown

Charges could come this fall as part of a new batch of insider trading cases.

----

Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent

Revolution Medicines attracted takeover interest but decided to go it alone. This week's FDA approval of its pancreatic cancer pill is the payoff.


(END) Dow Jones Newswires

August 28, 2026 19:15 ET (23:15 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center